Pure Antiestrogens The Most Important Advance in the Endocrine Therapy of Breast Cancer since 1896?a
- 1 April 1996
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 784 (1) , 325-335
- https://doi.org/10.1111/j.1749-6632.1996.tb16247.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Responses to Pure Antiestrogens (ICI 164384, ICI182780) in Estrogen‐Sensitive and‐Resistant Experimental and Clinical Breast CanceraAnnals of the New York Academy of Sciences, 1995
- Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestinsEuropean Journal Of Cancer, 1993
- Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF‐7 cell culturesInternational Journal of Cancer, 1993
- Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Effect of Estrogen and Antiestrogens on Cell Proliferation and Synthesis of Secreted Proteins in the Human Breast Cancer Cell Line MCF-7 and a Tamoxifen Resistant Variant Subline, AL-1Acta Oncologica, 1992
- A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the molybdate-stabilized oestrogen receptorThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cellsJournal of Molecular Endocrinology, 1989
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapyEuropean Journal of Cancer and Clinical Oncology, 1987